News


Calyxt to Participate in Fireside Chat at the 34th Annual Roth Conference

Calyxt to Participate in Fireside Chat at the 34th Annual Roth Conference

Roseville, MN – Tuesday, March 8, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that...
Read More
Calyxt Reports Fourth Quarter and Full Year 2021 Financial Results

Calyxt Reports Fourth Quarter and Full Year 2021 Financial Results

Reported achievement of milestones in the operationalization of its BioFactory™ production system, including the startup of its initial 200-liter pilot...
Read More

Calyxt Announces Closing of SEC-Registered Offering of Common Stock, Pre-Funded Warrants to Purchase Common Stock and Warrants to Purchase Common Stock

ROSEVILLE, Minn., February 23, 2022/PR Newswire/ — Calyxt, Inc. (NASDAQ: CLXT) (“Calyxt” or the “Company”), a plant-based synthetic biology company,...
Read More

Calxyt, Inc. Announces Pricing of $10.9 Million SEC-Registered Offering of Common Stock and Warrants

ROSEVILLE, Minn., February 17, 2022 /PR Newswire/ — Calyxt, Inc. (NASDAQ: CLXT) (“Calyxt” or the “Company”), a plant-based synthetic biology...
Read More
Calyxt Appoints Gerry Nuovo as Senior Vice President of Business Development

Calyxt Appoints Gerry Nuovo as Senior Vice President of Business Development

Roseville, MN – Monday, February 7, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that...
Read More
Next »
« Previous